Skip to main content
Year archive

Biotest AG — 2013 filings

All 52 regulatory filings released by Biotest AG (BIO3) in 2013, sourced directly from the official regulator.

52 Filings
2013 Period
2013 filings (52)
Filing Released Lang
Biotest AG: Biotest receives marketing authorisation for Albiomin(R) in Brazil and approval for commissioning of expanded albumin production
Regulatory Filings
2013-12-20 English
Biotest AG: Clinical Study with Indatuximab Ravtansine (BT-062) in Multiple Myeloma shows good Tolerability and encouraging Efficacy in Combination with Lenalidomide and Dexamethasone
Regulatory Filings
2013-12-10 English
Biotest AG: Biotest-EpiVax Collaborative Research Targets New, Non-Immunogenic Treatment for Hemophilia A
Regulatory Filings
2013-12-03 English
Datum:26.11.2013
AGM Information
2013-11-26 German
Biotest AG: Biotest Pharmaceuticals Honoured with the 2013 Greater Miami Chamber of Commerce International Business Leadership Award for 'Business Expansion'
Regulatory Filings
2013-11-20 English
Biotest AG: Biotest increases guidance significanty
Earnings Release 9M 2013
2013-11-12 English
Biotest AG: Managing Board increases guidance 2013
Earnings Release FY 2013
2013-11-12 English
Investor Presentation 2013
Investor Presentation
2013-11-12 German
Investor Presentation 2013
Investor Presentation
2013-11-12 English
Q3 Report 2013
Interim / Quarterly Report 9M 2013
2013-11-12 German
Biotest AG: Biotest presents the results of a Phase II study of tregalizumab (BT-061) at the American College of Rheumatology (ACR) Annual Meeting in San Diego
Regulatory Filings
2013-10-28 English
Biotest AG: Biotest AG successfully placed a Schuldschein of EUR 210 m.
Capital/Financing Update
2013-10-24 English
Biotest AG: Biotest supports the 'Project Recovery' in turning unused blood products from Canadian blood donations into hemophilia medicine for developing countries
Environmental & Social Information
2013-10-15 English
Biotest AG: Biotest AG opens three further plasmapheresis centers in Hungary and the USA
Regulatory Filings
2013-10-11 English
Biotest AG: Biotest increases earnings after tax by 55%
Earnings Release H1 2013
2013-08-13 English
Investor Presentation 2013
Investor Presentation
2013-08-13 English
Investor Presentation 2013
Investor Presentation
2013-08-13 German
Q2 Report 2013
Interim / Quarterly Report H2 2013
2013-08-13 German
Biotest AG: First patient treated with CivacirTM after Hepatitis C induced liver transplantation in Biotest's Phase III clinical trial
Legal Proceedings Report
2013-08-05 English
Datum:30.07.2013
Notice of Dividend Amount
2013-07-30 German
Investor Presentation 2013
Investor Presentation
2013-07-08 German
Investor Presentation 2013
Investor Presentation
2013-07-08 English
DGAP-DD: Biotest AG english
Director's Dealing
2013-07-01 English
DGAP-DD: Biotest AG english
Director's Dealing
2013-07-01 English
Biotest AG: Biotest AG successfully completes capital increase 2013: New shares were oversubscribed, Issuing volume amounts to EUR 76 million
Capital/Financing Update
2013-06-26 English
Investor Presentation 2013
Investor Presentation
2013-06-19 German
Investor Presentation 2013
Investor Presentation
2013-06-19 English
Biotest AG: Biotest AG sets the subscription price and the offer price for the new preferred shares at EUR 52.00 per preferred share
Capital/Financing Update
2013-06-10 English
Biotest AG: Biotest AG has resolved to utilise its authorised capital with subscription rights for existing shareholders
Capital/Financing Update
2013-06-10 English
DGAP-DD: Biotest AG english
Director's Dealing
2013-05-27 English
DGAP-DD: Biotest AG english
Director's Dealing
2013-05-27 English
DGAP-DD: Biotest AG english
Director's Dealing
2013-05-22 English
DGAP-DD: Biotest AG english
Director's Dealing
2013-05-22 English
Biotest AG: Biotest AG: Annual general meeting approves increase of dividend
AGM Information
2013-05-08 English
Biotest AG: Biotest AG plans a capital increase and rights issue
Capital/Financing Update
2013-05-08 English
Investor Presentation 2013
Investor Presentation
2013-05-08 German
Investor Presentation 2013
Investor Presentation
2013-05-08 English
Q1 Report 2013
Interim / Quarterly Report Q1 2013
2013-05-08 German
Datum:18.04.2013
Annual Report FY 2012
2013-04-18 German
Biotest Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 08.05.2013 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2013-03-26 German
Biotest AG: Biotest increases Profit before Tax by 28%
Earnings Release FY 2012
2013-03-25 English
Annual Report 2012
Annual Report FY 2012
2013-03-25 English
Geschäftsbericht 2012
Annual Report FY 2012
2013-03-25 German
Investor Presentation 2013
Investor Presentation
2013-03-25 English
Investor Presentation 2013
Investor Presentation
2013-03-25 German
Biotest AG: Biotest decides to move into biggest Phase IIb trial in company history
Regulatory Filings
2013-03-21 English
Biotest AG: Biotest increases earnings before taxes by 28%
Earnings Release FY 2012
2013-02-21 English
Biotest AG: Biotest announces launch of BIVIGAM(TM)in the United States
Regulatory Filings
2013-02-04 English
Biotest AG: Increase in Earnings after Tex for Fiscal Year 2012
Earnings Release FY 2012
2013-01-22 English
Biotest AG: Biotest AG with new sales and distribution activities in Russia and Greece
M&A Activity
2013-01-21 English
Biotest AG: Biotest Announces Strategic Long-Term Manufacturing, Supply and License Agreement
M&A Activity
2013-01-16 English
Biotest AG: Biotest AG's Supervisory Board extends the term of CEO Prof. Schulz and appoints Dr. Flo to the Board of Management
Board/Management Information
2013-01-09 English